NASDAQ: VRTX $55 Billion Large-Cap. Nasdaq 100. S&P 500. Health Care Sector. Biotech & Pharma Industry. 5 Year Return 66%. 1 Year Return 4%. 2020 YTD Return 6%. Since Earnings 26%.
For Starters
The 52 Week Low is $194.20 set on Thu, Oct 31, 2019.
The 52 Week High is $304.00 set on Mon, Jul 20, 2020.
The All-Time High is $304.00 set on Mon, Jul 20, 2020.
Earnings Per Share
Price To Earnings Ratio
Dividend Yield
Dividend Rate
Ex-Dividend Date
Dividend Payment Date
Dividend Frequency
Dividend History
Vertex Pharmaceuticals trades on the NASDAQ. VRTX's market cap is 55.3 Billion.
Vertex Pharmaceuticals discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex's pipeline also includes therapies for cancer, pain, inflammatory diseases, influenza, and other rare diseases.
Track your portfolio and more.
